A new trial has shown for the first time that a combination of three targeted therapies can improve survival in patients with advanced colorectal cancer with a specific mutation.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,